L

Laurus Labs Ltd

PharmaceuticalsMidcap

About the company

Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 11 analysts offering recommendations for Laurus Labs Ltd

46%

Buy

27%

Hold

27%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio144.8534.79
PB Ratio11.285.49
Dividend Yield0.12%0.61%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions